Skip to content
healthcare.dev
Get a free key

Gattex

NDC 68875-0101, teduglutide, injection, powder, lyophilized, for solution, from Takeda Pharmaceuticals America, Inc..

Product NDC
68875-0101
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203441
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68875-0101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEDUGLUTIDE5 mg/.5mL

Pharmacologic classes

Analogs/Derivatives [Chemical/Ingredient]; GLP-2 Analog [EPC]; Glucagon-Like Peptide 2 [Chemical/Ingredient]; Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]

Package NDCNDC-11Package
68875-0101-26887501010230 VIAL in 1 CARTON (68875-0101-2) / .5 mL in 1 VIAL (68875-0101-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/66b69c1e-b25c-44d3-b5ff-1c1de9a516fa

Use it

Look up 68875-0101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68875-0101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68875-0101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.